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ABSTRACT  
Halogen bonding is nowadays a consolidated tool in chemistry. Only recently, the importance 
of halogen bonding has been demonstrated also in biological systems, owing to the presence of 
halogens in drugs.This interaction is due to the anisotropy of the electron density around the 
halogen that leads to the formation of the ‘σ-hole’, which is responsible for the interaction with a 
nucleophile site. Unfortunately, classical force fields used in the study of ligand-receptor systems 
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 2 
are not able to describe the ‘σ-hole’. Here, we propose a pseudo-atom based methodology able to 
correctly describe halogen bonding involving chlorine using classical force field. 
 
INTRODUCTION 
Halogen bonding (XB) is a highly directional, non-covalent interaction established between a 
halogen atom (X) covalently bonded to a donor group (D) and a nucleophilic site A, the halogen 
bonding acceptor, according to the scheme D–X∙∙∙A. The donor moiety D can range from another 
halogen atom to an organic or inorganic group, whereas the nucleophilic acceptor site is most 
often a lone pair on a heteroatom such as nitrogen, oxygen or sulfur. At first glance, the 
formation of halogen bonding appears a rather unexpected phenomenon as it involves the 
interaction between an electronegative, supposed spherical, species and a Lewis base. Actually, 
the electron density around a covalently bonded halogen atom is not uniformly distributed, 
exhibiting a depletion along the D–X bond axis in the region outward the bond itself, that is 
compensated by a relative increase in a belt around the bond axis. A simple and intuitive model 
to explain the origin of such anisotropy has been developed by Politzer and coworkers.
1
 
Compared to an isolated halogen atom, which has spherical symmetry and 5/3 average p electron 
population in each direction, the electronic structure of a halogen atom covalently bonded to 
another atom along the z axis can be approximately written as s
2
px
2
py
2
pz
1
.  The region of lower 
electron density along the extension of the D–X bond, denoted as σ-hole,2 generally reflects in a 
positive electrostatic potential which is responsible for the interaction with a nucleophile site.  
The size and depth of the σ-hole depend on the electron withdrawing capability of the donor 
group and on the nature of the halogen atom. A good correlation has been observed between the 
values of the electrostatic potential (ESP) on the σ-hole and the strength of halogen bond,3 
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 3 
although the electrostatic contribution is not the only energetic term giving rise to this 
interaction. Depending on the nature of the halogen and of the donor and acceptor groups, also 
dispersive forces can play a significant role.
4, 5
  
The persistent view of halogens as electronegative species has long prevented researchers to 
think to bonded halogens as responsible for even strong interactions with nucleophilic sites. Only 
in the past two decades, differently for the more explored hydrogen bonding (HB), the potential 
of XB in directing assembly phenomena has become to be explored. Thanks to its strength, 
directionality and intrinsic tunability, the latter resulting from the possibility to span the four 
halogen atoms, halogen bonding has found a plethora of possible applications in the most 
diversified fields of chemistry and biology, going from photoluminescent materials
6
 to nonlinear 
optics,
7
 supramolecular chemistry
8, 9
 and drug design.
10-14
 In addition, XB is ubiquitously present 
in biological systems, as pointed out by protein data bank (PDB) analysis.
18
 For a long time, 
halogenated drug molecules were predominantly adopted due to their increased metabolic 
stability and membrane permeability conferred by halogen atoms. It has been also shown that 
XB can compete with HB in stabilizing brominated DNA junctions.
10, 15
 In recent years it has 
been observed that halogen atoms can increase the drug-target affinity through XB, thus 
increasing drug activity of several orders of magnitude with respect to analogous non-
halogenated moieties.
11, 16, 17
 For these reasons, halogen bonding has been the subject of 
numerous computational studies on both molecular and macromolecular systems. At molecular 
level, highly correlated methods and density functional theory (DFT) have been largely used to 
study this interaction in gas-phase
19-22
 and in solution using continuum models of the solvent.
23-25
 
Quantum mechanics/molecular mechanics (QM/MM) methods have been used to describe the 
interaction of halogenated molecules with proteins.
18
 In this context, many efforts have been 
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made in the direction of correctly describe XB in the framework of classical force fields methods 
that are world-wide used to perform drug discovery and drug design studies. The main problem 
in classical force field description of halogen bonding is that computation of the electrostatic 
contribution to the interaction (which is generally the dominating term in XB) is based on a set 
of atomic-point charges, usually obtained exploiting a fitting procedure (Restrained ElectroStatic 
Potential, RESP
26
) to quantum mechanical ESP. This approach is completely misleading in the 
description of halogen bonding, which is based on the anisotropy of the electrostatic potential 
around the halogen atom (see the -hole concept illustrated above). Several solutions have been 
proposed through the years to fix this issue.
27
 Among these it is to be mentioned the introduction 
of multipoles replacing atomic centered point charges (at least on the atoms involved in the 
interaction), allowing a rigorous description of XB in biological systems at the cost of time 
demanding simulations and more complicate model with respect to the point charges one
28
 and 
several force fields, like OPLS3
29,30
 and the extended versions of AMOEBA
31
 and CGenFF
32
, 
designed specifically to treat this kind of non-covalent interaction. Other possible solutions
 
are 
force fields allowing for aspherical halogen atoms
33-35
 or force fields where an extra-point charge 
is introduced, directly linked to the halogen atom in the region outward the D–X bond, for the 
purpose of simulating the charge induced by the presence of the -hole. This strategy has been 
successfully implemented by different groups.
36-38
 In particular, Sironi and coworkers
38
 applied it 
to the study of brominated and iodinated ligands complexing proteins. Interestingly, the same 
approach applied for the description of weaker halogen bonds involving chlorine resulted in 
rather poor results (it has not been possible, differently from iodinated and brominated 
compounds to reproduce crystallographic data involving chlorinated ligands). Indeed, chlorine is 
the less polarizable among the halogens
39
 (excluding fluorine that in most cases is not able to 
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 5 
give rise to halogen bonding
40
) and therefore it is envisaged that it requires a more sophisticated 
description of the ESP anisotropy around it. The necessity to improve the 1Pa methodology has 
been also pointed out in other papers from MacKerrel et al.
41, 42
  
In this work, we propose a simple and effective way, based on the use of a set of extra-point 
charges or pseudo-atoms (Pa’s), properly placed around the halogen atom, to describe halogen 
bonding involving chlorine in biological systems. The proposed approach has been applied to the 
investigation of XB between a series of chlorinated model systems and the carbonyl oxygen of 
the capped alanine (see Figure 1) through molecular mechanics (MM) geometry optimization. 
One brominated derivative has been as well included to check the generality of our procedure. 
These model systems have been chosen to simulate real halogenated ligands such as those 
present in biological systems, as it has been shown that almost always, in the PDB, halogen 
atoms involved in halogen bonding are linked to an aromatic ring.
3,43
 Aromatic, rather than 
aliphatic, halogenated ligands are also important from an applicative point of view owing to the 
greater strength of the associated C–X bonds, reducing the possible release of halogen anions in 
the organism. The substituents on the aromatic ring, their position and the nature of the ring itself 
have been varied to tune the XB strength in order to validate our methodology for a wide range 
of halogen bonding interactions. We found out that the proposed approach allows to significantly 
improve the geometrical parameters (i.e., interaction distances and angles) of the chlorine XB 
interaction with respect to the previous pseudo-atom strategy,
36-38
 using as benchmark the results 
obtained at M06-2X
44
/6-311++G(d,p) level. Moreover, we show that a re-parametrization of the 
general AMBER force field (GAFF
45
) van der Waals parameters for chlorine is necessary to 
have an effective description of chlorine XB in biological systems, in good agreement with the 
results obtained by Scholfield et al.
34
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Figure 1. Chlorinated (AL) or brominated (M) model systems chosen to study halogen bond 
with the carbonyl oxygen of the capped alanine through the Pseudo-atom(s) strategy.  
 
MATERIALS AND METHODS 
The structures of eleven halogenated molecules complexed by capped alanine (see Figure 1), 
taken as benchmark in the MM energy minimization, were obtained by quantum mechanical 
geometry optimizations using the software Gaussian 09.
46
 In particular, for all the complexes 
DFT (BSSE free) calculations were performed by using the M06-2X
44
 functional, an hybrid 
meta-GGA functional that is highly recommended to study halogen bonding and other non-
covalent interactions;
25
 the 6-311++G(d,p) basis set has been used for all atoms in the 
complexes.  
The partial atomic charges for the ligands were derived exploiting the RESP procedure, as 
implemented in AMBER11, on the ESP as obtained by RHF/6-31G(d,p) Gaussian09 
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 7 
calculations. To evaluate the goodness of the RESP fitting to the RHF electrostatic potential, the 
relative root mean square error (RRMS) has been monitored. Two different dispositions of 
pseudo-atoms have been then tested (see Figure 2): in the first one (‘1Pa’ disposition, A), a 
single pseudo-atom (Pa) has been added along the extension of the D–X bond, pointing towards 
the XB acceptor, and several X–Pa distances have been tested as described in the Results section; 
in the second one (‘5Pa’ disposition, B),  five Pa’s were added to the halogenated ligands: one in 
the same position as in ‘1Pa’ and the other four along two directions, orthogonal each other and 
perpendicular to the D–X bond, so that each of these four Pa’s is the vertex of a square with the 
chlorine atom in the center. Also in this case several X–Pa distances have been tested. To 
parametrize the halogenated molecules the GAFF
45,47 
force fields have been adopted, while for 
the capped alanine the ff99SBildn force field has been employed.
48
 
 
 
Figure 2. Dispositions of pseudo-atoms adopted to describe the anisotropy of electron density 
around the halogen atoms (X, Pa and C stand for halogen, pseudo-atom and carbon, 
respectively). A: ‘1Pa’ disposition where one Pa is used to simulate the charge of the -hole. B: 
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 8 
‘5Pa’ disposition, where one Pa (in yellow) is used to simulate the charge of the -hole and the 
other four surrounding the halogen are used to enhance the negative belt. 
 
In order to better reproduce the DFT geometrical parameters (interaction distances and angles) 
of halogen bonding, different values of the van der Waals radius parameter for the chlorine atom 
have been tested in all the analyzed systems, as described in the Results section, while the well 
energy depth (the energy minimum for the vdW interaction) has been kept fixed to 0.265 kcal 
mol
-1
. Such tests showed that a lowering of the chlorine vdW radius parameter improves the 
description of the XB geometrical parameters and it is also consistent with the variation of the 
non-bonded parameters for bromine and iodine passing from the original Amber force field
40 
to 
the more recent one. 
The ACPYPE utility has been used to convert the AMBER input files into the Gromacs ones. 
MM energy minimizations were then performed with Gromacs 5.0.7
42
 package on all complexes 
either in the native form and after pseudo-atoms insertion for both Pa(s) dispositions. We 
adopted 10000 steps of steepest descendent minimization, with 10 steps of conjugate gradient 
minimization for every step of steepest minimization.  
To compare the XB geometrical parameters as obtained from classical energy minimization 
(em) using the pseudo-atom(s) and DFT approaches, the percentage errors (Sdistance and Sangle), as 
defined in equations (1) and (2), have been used. 
          
          
    
  (1) 
       
              
      
  (2) 
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 9 
where dem and angem are the interaction distances and angles, respectively, as obtained from the 
classical approach, while dDFT and angDFT are the corresponding parameters as obtained from 
M06-2X/6-311++G(d,p) geometry optimization. 
 
RESULTS AND DISCUSSION 
Halogen bonding established in ten chlorinated model systems with capped alanine (see Figure 
1) has been studied by means of Molecular Mechanics energy minimization with the purpose of 
developing a new strategy to be used in classical force fields methods, owing to the failure of the 
previously reported pseudo-atom methods
36-38
 in describing chlorine-based XB. The new 
approach is based on the use of a set of pseudo-atoms, Pa’s, in place of a single one as previously 
proposed.
36-38
 The model systems were properly chosen to simulate halogenated ligands in 
protein-ligand complexes, while the capped alanine has been used because it is a typical XB 
acceptor in protein-ligand systems, as underlined by a PBD survey.
18
 As benchmark for testing 
our model systems, the BSSE-free M06-2X/6-311++G(d,p) optimized XO distances and C–
XO angles have been used. Several Pa’s models as obtained by varying the number of Pa’s and 
their dispositions, their distances from the halogen and the vdW radius of the halogen have been 
tested. The case of no Pa has been as well taken into account.  
The disposition of the Pa’s around the halogen is shown in Figure 2. While in the previously 
proposed ‘1Pa’ strategy (Figure 2A) a single Pa was used to reproduce the positive charge of the 
-hole, in the present ‘5Pa’ scheme (Figure 2B) four additional Pa’s are added to describe the 
negative belt around the halogen atom. As it can be observed from the electrostatic potential 
maps shown in Figure 3, the full set of extra-point charges allows to reproduce the anisotropy of 
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 10 
the quantum mechanical ESP by using classical methods, in contrast to the case in which no 
pseudo-atom has been introduced. 
 
 
Figure 3. Electrostatic potential mapped onto the electron density surface (0.002 electrons au
-3
) 
of 1-chloro-2,4,6-trifluorobenzene (A), calculated at RHF/6-31G(d) level of theory (D) or using 
the RESP procedure without pseudo-atom(s) (B) and after five (C) pseudo-atoms addition at 1.8 
Å from the chlorine atom. 
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The first important result of the present investigation is that for all the chlorinated systems the 
introduction of one or more Pa’s allows to describe the XB interaction through classical energy 
minimization calculations, while the halogen bonding interaction is completely lost (meaningless 
geometrical parameters have been observed) if no extra-point charge is included in the model 
(see Table 2 for results obtained on chlorobenzene using, as an example, 1.748 Å as vdW radius 
for chlorine and 1.8 Å as Cl–Pa(s) distance). However, the inclusion of a single Pa in most cases 
does not allow to correctly reproduce the DFT geometrical parameters for the XB interaction 
(see Figures 4 and S1-S10, and Tables S1 and S2), unlike what previously reported for 
brominated and iodinated systems.
38
 On the other hand, the ‘5Pa’ strategy brings an important 
improvement in the chlorine XB description, as denoted by a lowering of the percentage 
geometrical errors with respect to DFT results. The fact that the simpler ‘1Pa’ approach is not 
adequate in the case of chlorine could be probably related to the weaker interactions established 
by this atom with respect to those with the heavier halogens, which is a consequence of a less 
pronounced -hole. Because of this, the anisotropy of the electrostatic potential around the 
chlorine atom needs to be described in a finer way, which can be realized by introducing more 
than one Pa.  
According to Hobza et al.,
36
 the optimum distance of the pseudo-atom (explicit sigma hole, 
ESH, in their model) from the halogen should be shorter than the halogen vdW parameter to 
avoid numerical instabilities in simulations. On the other hand, it has been noted that placing the 
Pa too close to the halogen could lead to an overestimation of the extra-point charge. For this 
reason, we decided to test the disposition of the extra-point charges around the halogen atom by 
varying both the X–Pa distance and the chlorine vdW radius, in order to get the better 
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compromise for the choice of the X–Pa distance. To this aim, three different X–Pa distances (1.4, 
1.6 and 2.0 Å) have been considered in both strategies (1Pa and 5Pa) for each vdW parameter 
used. The chlorine GAFF vdW parameter has been varied from 1.95 Å, that is the default value, 
to 1.748 and 1.648 Å.  
As shown in Tables S1, S2 and in Figures S1 through S10, it was not possible to highlight any 
trends in the behavior of the Sdistance and Sangle percentage errors upon variation of the X–Pa 
distances, denoting some insensitiveness of the XB geometry on this parameter in the range here 
considered.  On the other hand, concerning the chlorine GAFF VdW parameter, it can be inferred 
that the default vdW radius of chlorine is not suitable for describing this interaction, because, 
almost always, it gives the worst Sdistance and Sangle errors with respect to the others two tested 
values (1.748 and 1.648 Å). This is true for either ‘1Pa’ and ‘5Pa’ strategies but it is more 
evident for the latter one, probably because in the former case the vdW parameter effect is 
“masked” by the greater error introduced by the coarse description of the electrostatic potential 
given by the ‘1Pa’ strategy. The necessity to reduce the vdW radius with respect to the original 
implemented value, in order to correctly describe XB, was already evidenced for bromine and 
iodine, whose vdW radii have been in fact modified from 2.22 to 2.02 Å (Br) and from 2.35 to 
2.15 Å (I) passing from the original
45
 to the improved version of GAFF.
45
 Both of the new 
shorter GAFF vdW radii here tested for chlorine allow to improve the results obtained for all the 
model systems studied, though no systematic differences are observed passing from 1.748 to 
1.648 Å. This conclusion doesn’t claim to be a rigorous re-parametrization of the chlorine GAFF 
vdW radius, but should be view as an indication that this parameter should be revised in future 
GAFF force field versions. 
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It is to be noted that the MM minimization, while providing positive charge, as expected, for 
the ‘-hole’ Pa, resulted in either negative charges for the ‘lateral’ Pa’s in all chlorinated 
derivatives or positive charges for bromobenzene, which was included in our investigation as a 
check of our procedure (see Tables 3 and 4). This observation is in good agreement with the 
results of a charge density investigation by Espinosa et al.,
50
 who explored the differences 
between the chlorine and bromine -hole “architectures” based on analysis of the Laplacian of 
electron density, 2(r), for a series of halogenated molecules. This analysis clearly shows that 
for chlorine it is possible to observe an extended valence shell charge concentration (VSCC) 
region, containing either the charge concentration (CC) and charge depletion (CD) sites. On the 
other side, for bromine a far more reduced VSCC region is observed, containing only the CC 
sites, while the CD sites belong to a large region of positive 2(r) (which corresponds to a large 
portion of positive electrostatic potential) surrounding the bromine atom. This topology of 2(r) 
is in agreement with the positive values of the four lateral extra-point charges in the case of 
bromobenzene. Moreover, it can explain also the reason why the ‘5Pa’ disposition is necessary 
for correctly describe chlorine halogen bonding: using only one extra-point charge linked to 
chlorine in the position of the -hole could induce an underestimation of the electrostatic charge 
related to the -hole (because of the extended VSSC region). By introducing the four lateral 
Pa(s), describing the “negative belt” of the halogen’s ESP, the charge of the central Pa fits more 
accurately the real -hole charge derived from QM calculations.  
The inadequacy of using only one extra-point charge to describe the anisotropy of the 
electrostatic potential around halogen atoms was pointed out also by Hage et al.
35
 In particular 
their observation on the requirement of the quadrupolar contribution to reproduce 
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thermodynamic properties of halogen bonding (in particular for lighter halogens) by using hybrid 
(PC/MTP) approaches would help corroborate the ‘5Pa’ model here proposed.  
 
 
Table 2. Halogen bonding interaction distances and angles for the chlorobenzene-capped alanine 
dimer, computed with molecular mechanics using 0, 1 and 5 pseudo-atoms and with M06-2X/6-
311++G(d,p) geometry optimization.
a 
Chlorobenzene Distance/Å Angle/° 
No Pseudo-atom Lost Lost 
1 Pseudo-atom 3.02 169.97 
5 Pseudo-atoms 3.24 161.14 
M06-2X/6-311++G(d,p) 3.17 160.11 
a
MM calculations performed using 1.748 Å as VdW parameter for the chlorine atom and 1.8 Å 
as Pa(s) distances from chlorine. 
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Figure 4. Percentage errors on halogen bonding distances (x-axis) and angles (y-axis), for the ten 
chlorinated systems studied in this work. ‘5Pa’ strategy in red, ‘1Pa’ strategy in blue 
(calculations performed using 1.748 Å as vdW parameter for the chlorine atom and 2.0 Å as 
Pa(s) distances from the central halogen). 
Table 3. Selected RESP derived atomic point charges (in amu) in chlorobenzene: Carbon linked 
to chlorine, chlorine, pseudo-atom representing the -hole and the four lateral pseudo-atoms. 1.8 
Å as Pa(s) distances from chlorine have been used. 
 C Cl ‘-hole’ Pa Pa Pa Pa Pa 
No Pa -0.01 -0.13 - - - - - 
1 Pa 0.02 -0.15 0.01 - - - - 
5 Pa 0.30 -0.23 0.04 -0.01 -0.01 -0.01 -0.01 
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Table 4. Selected RESP derived atomic point charges (in amu) in bromobenzene: Carbon linked 
to bromine, bromine, pseudo-atom representing the -hole and the four lateral pseudo-atoms. 1.8 
Å as Pa(s) distances from chlorine have been used. 
 C Br ‘-hole’ Pa Pa Pa Pa Pa 
No Pa -0.12 -0.09 - - - - - 
1 Pa 0.20 -0.30 0.06 - - - - 
5 Pa 0.15 -0.32 0.03 0.02 0.02 0.02 0.02 
 
For all studied systems, a decreasing of the RRMS error related to the RESP procedure has 
been observed passing from no to one and then to five Pa’s. As pointed out in the previous 
pseudo-atoms studies for halogen bond,
36-38
 the introduction of an extra point charge linked to 
the halogen atom leads to an improvement of the description of the electrostatic potential around 
the halogens. The introduction of more than one Pa reduces only slightly the RRMS error, much 
less than what obtained passing from zero to one Pa. However, it is well known that small 
changes in the molecular electrostatic potential may involve even large variations in the 
chemistry of non-covalent interactions. Accordingly, the great improvement in the geometrical 
parameters of halogen bonded complexes observed upon insertion of more than one Pa derives 
from small modifications of the ESP, though they result in only limited improvement in the 
values the RRMS associated to the RESP procedure. 
 
CONCLUSIONS 
A series of chlorinated model systems have been studied by molecular mechanics energy 
minimization exploiting a set of extra-point charges to simulate the -hole and the negative belt 
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characterizing the electron density distribution around the chlorine atom. Differently from the 
previously reported pseudo-atom (‘1Pa’) approach,36-38 the ‘5Pa’ strategy here proposed is 
demonstrated to well reproduce quantum mechanical geometrical parameters for halogen 
bonding interaction of the model systems with the carbonyl oxygen of the capped alanine. The 
model systems have been chosen to either reproduce real systems that are likely to be 
encountered in PDB and test the strategy to a rather extended range of XB strengths.  
We found out that the MM description of chlorine XB has been greatly improved by the 
introduction of more than one Pa’s in all the chlorinated model systems here investigated. This 
improvement is evident from the lowering of the percentage errors on the interaction distances 
and angles, as referred to benchmark M06-2X/6-311++G(d,p) geometry optimizations, when 
going from the ‘1Pa’ to the ‘5Pa’ methodology. The same improvement was not observed in the 
case of bromobenzene, suggesting the correctness of the ‘1Pa’ strategy in the description of 
halogen bonding when bromine atoms are involved. 
Moreover, it has been shown (through testing of different vdW radius values) that a re-
parametrization of the chlorine GAFF van der Waals radius should be taken into account to 
obtain a proper halogen bonding description.  
Further development of this methodology will comprehend either testing our Pa’s strategy on 
other model compounds (including different halogen bond acceptor) and performing molecular 
dynamic simulations on condensed phase systems (like complexes between proteins and 
chlorinated ligands).  
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Geometrical parameters (Tables S1S3) and two-dimensional plots of the Sangle and Sdistance 
errors for all the studied XB systems  (Figures S1S10). 
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